Abstract
Chronic kidney disease (CKD) is an independent risk factor for coronary artery disease (CAD), and is associated with more complex coronary pathologies such as multivessel disease and left main involvement. Greater reductions in renal function are associated with increasingly poor outcomes following revascularization therapy. The optimal revascularization approach for obstructive CAD in stable or unstable coronary syndromes in CKD has not been defined as there is a lack of sufficiently powered randomized data in this patient subset. While coronary artery bypass grafting (CABG) appears to be associated with better long-term survival and less long-term ischemic events than percutaneous coronary intervention (PCI), the choice of revascularization therapy should be individualized, taking into account patient co-morbidities, functional status, and preference.
Disclosures
All authors declare no conflict of interest.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154–69.
Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140(3):167–74.
Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA. Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. J Am Soc Nephrol: JASN. 2003;14(12):3233–8.
Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002;137(7):563–70.
Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. ‘United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis Off J Natl Kidney Found. 2012;59(1 Suppl 1):A7. e1–420.
Herzog CA. How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol: JASN. 2003;14(10):2556–72.
Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002;13(7):1918–27.
Shroff GR, Solid CA, Herzog CA. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation (New York, NY). 2013;127(18):1861–9.
Tadros GM, Herzog CA. Percutaneous coronary intervention in chronic kidney disease patients. J Nephrol. 2004;17(3):364–8.
Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006;296(11):1377–84.
McCullough PA. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med. 2002;3(2):71–6.
Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41(1):47–55.
Baber U, Stone GW, Weisz G, Moreno P, Dangas G, Maehara A, et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S53–61.
Charytan D, Kuntz RE, Mauri L, DeFilippi C. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis. 2007;49(3):409–16.
Joki N, Hase H, Takahashi Y, Ishikawa H, Nakamura R, Imamura Y, et al. Angiographical severity of coronary atherosclerosis predicts death in the first year of hemodialysis. Int Urol Nephrol. 2003;35(2):289–97.
Wizemann V. Coronary artery disease in dialysis patients. Nephron. 1996;74(4):642–51.
Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290(13):697–701.
Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int. 2004;65(6):2380–9.
Joki N, Hase H, Nakamura R, Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transpl Off Publ Eur Dial Transplant Assoc – Eur Renal Assoc. 1997;12(4):718–23.
Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int. 2002;62(5):1784–90.
Di Benedetto A, Marcelli D, D’Andrea A, Cice G, D’Isa S, Cappabianca F, et al. Risk factors and underlying cardiovascular diseases in incident ESRD patients. J Nephrol. 2005;18(5):592–8.
Aggarwal A, Kabbani SS, Rimmer JM, Gennari FJ, Taatjes DJ, Sobel BE, et al. Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk. Am J Kidney Dis. 2002;40(2):315–22.
Sreedhara R, Itagaki I, Lynn B, Hakim RM. Defective platelet aggregation in uremia is transiently worsened by hemodialysis. Am J Kidney Dis Off J Natl Kidney Found. 1995;25(4):555–63.
Schindler R, Boenisch O, Fischer C, Frei U. Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol. 2000;53(6):452–9.
Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am J Med Sci. 1998;316(2):94–104.
Raine AE, Margreiter R, Brunner FP, Ehrich JH, Geerlings W, Landais P, et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transpl Off Publ Eur Dial Transplant Assoc – Eur Renal Assoc. 1992;7 Suppl 2:7–35.
Aronow WS, Ahn C, Mercando AD, Epstein S. Prognostic significance of silent ischemia in elderly patients with peripheral arterial disease with and without previous myocardial infarction. Am J Cardiol. 1992;69(1):137–9.
Bansal N. Clinically silent myocardial infarctions in the CKD community. Nephrol Dial Transplant. 2012;27(9):3387–91.
Nesto RW, Watson FS, Kowalchuk GJ, Zarich SW, Hill T, Lewis SM, et al. Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy. Am Heart J. 1990;120(5):1073–7.
Surana SP, Riella LV, Keithi-Reddy SR, Charytan DM, Singh AK. Acute coronary syndrome in ESRD patients. Kidney Int. 2009;75(5):558–62.
K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):16–153.
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):2574–609.
Serruys PW, Morice M-C, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–72.
Zheng H, Xue S, Lian F, Huang R-t, Z-I H, Wang Y-Y. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease. Eur J Cardiothorac Surg. 2013;43(3):459–67.
Ix JH, Mercado N, Shlipak MG, Lemos PA, Boersma E, Lindeboom W, et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J. 2005;149(3):512–9.
Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002;106(17):2207–11.
Agirbasli M, Weintraub WS, Chang GL, King SB, Guyton RA, Thompson TD, et al. Outcome of coronary revascularization in patients on renal dialysis. Am J Cardiol. 2000;86(4):395–9.
Hemmelgarn BR. Survival after coronary revascularization among patients with kidney disease. Circulation (New York, NY). 2004;110(14):1890–5.
Rinehart AL. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis. 1995;25(2):281–90.
Ohmoto Y, Ayabe M, Hara K, Sugimoto T, Tagawa H, Fukuda S, et al. Long-term outcome of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in patients with end-stage renal disease. Jpn Circ J. 1999;63(12):981–7.
Nevis IF, Mathew A, Novick RJ, Parikh CR, Devereaux PJ, Natarajan MK, et al. Optimal method of coronary revascularization in patients receiving dialysis: systematic review. Clin J Am Soc Nephrol. 2009;4(2):369–78.
Kannan A, Poongkunran C, Medina R, Ramanujam V, Poongkunran M, Balamuthusamy S. Coronary revascularization in chronic and end-stage renal disease: a systematic review and meta-analysis. Am J Ther. 2014.
Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2014;114(4):555–61.
King 3rd SB, Marshall JJ, Tummala PE. Revascularization for coronary artery disease: stents versus bypass surgery. Annu Rev Med. 2010;61:199–213.
Kar S, Coats W, Aggarwal K. Percutaneous coronary intervention versus coronary artery bypass graft in chronic kidney disease: optimal treatment options. Hemodial Int Int Symp Home Hemodial. 2011;15 Suppl 1:S30–6.
Anderson RJ, O’Brien M, MaWhinney S, VillaNueva CB, Moritz TE, Sethi GK, et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5. Kidney Int. 1999;55(3):1057–62.
Cooper WA, O’Brien SM, Thourani VH, Guyton RA, Bridges CR, Szczech LA, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113(8):1063–70.
Gibbons RJ, Fihn SD. Coronary revascularization: new evidence, new challenges. Ann Intern Med. 2007;147(10):732–4.
Deo SV, Shah IK, Dunlay SM, Erwin PJ, Dillon JM, Park SJ. Myocardial revascularisation in renal dysfunction: a systematic review and meta-analysis. Heart Lung Circ. 2013;22(10):827–35.
Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int. 1999;56(1):324–32.
Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339(12):799–805.
Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(13):1598–660.
Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, Stenestrand U, et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009;120(10):851–8.
Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):2354–94.
Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). Am J Cardiol. 2002;90(11):1246–9.
Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E, Wallentin L. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet. 2006;368(9540):998–1004.
Damman P, Hirsch A, Windhausen F, Tijssen JGP, de Winter RJ. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial a randomized comparison of an early invasive versus selective invasive management in patients with non–ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2010;55(9):858–64.
Woudstra P, Damman P, Clayton T, Wallentin L, Lagerqvist B, Fox K, et al. Routine invasive versus selective invasive strategy and long-term outcomes in patients with reduced renal function presenting with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2012;59(13 Suppl 1):E392–E.
Santopinto JJ, Fox KAA, Goldberg RJ, Budaj A, Piñero G, Avezum A, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003;89(9):1003–8.
Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau J-L, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285–95.
Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259–64.
Chen Y-Y, Wang J-F, Zhang Y-J, Xie S-L, Nie R-Q. Optimal strategy of coronary revascularization in chronic kidney disease patients: a meta-analysis. Eur J Intern Med. 2013;24(4):354–61.
Best PJM, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes Jr DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39(7):1113–9.
Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol: JASN. 2003;14(9):2373–80.
Best PJ, Berger PB, Davis BR, Grines CL, Sadeghi HM, Williams BA, et al. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. J Am Coll Cardiol. 2004;44(9):1786–91.
Osten MD, Ivanov J, Eichhofer J, Seidelin PH, Ross JR, Barolet A, et al. Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention. Am J Cardiol. 2008;101(6):780–5.
El-Menyar AA, Al Suwaidi J, Holmes Jr DR. Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency. Mayo Clin Proc. 2010;85(2):165–71.
Krotin M, Vukovic D, Stojanovic O, Milovanovic B, Celeketic D, Blagojevic R. Prognostic value of dobutamine stress echocardiography in patients with terminal renal insufficiency undergoing hemodialysis--a 5-year follow up. Med Pregl. 2007;60(7–8):333–7.
Francis GS, Sharma B, Collins AL, Helseth HK, Comty CM. Coronary-artery surgery in patients with end-stage renal disease. Ann Intern Med. 1980;92(4):499–503.
Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2002;55(1):66–72.
Tsutsui M, Shimokawa H, Tanaka S, Yoshihara S, Higuchi S, Matsuguchi T, et al. Granulocyte activation in restenosis after percutaneous transluminal coronary angioplasty. Jpn Circ J. 1996;60(1):27–34.
Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–9.
Athappan G, Ponniah T. Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature. Minerva Cardioangiol. 2009;57(3):291–7.
Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, et al. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. J Am Coll Cardiol. 2011;58(15):1569–77.
Manabe S, Shimokawa T, Fukui T, Fumimoto KU, Ozawa N, Seki H, et al. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome? J Card Surg. 2009;24(3):234–9.
Hiremath S. Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates. Clin J Am Soc Nephrol. 2009;4(8):1347–55.
Tsai TT, Maddox TM, Roe MT, et al. Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA. 2009;302(22):2458–64.
Alexander KP, Chen AY, Roe MT, et al. EXcess dosing of antiplatelet and antithrombin agents in the treatment of non–st-segment elevation acute coronary syndromes. JAMA. 2005;294(24):3108–16.
Liu JY, Birkmeyer NJO, Sanders JH, Morton JR, Henriques HF, Lahey SJ, et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circulation. 2000;102(24):2973–7.
Sezai A, Nakata K, Hata M, Yoshitake I, Wakui S, Hata H, et al. Long-term results of dialysis patients with chronic kidney disease undergoing coronary artery bypass grafting. Ann Thoracic Cardiovasc Surg Off J Assoc Thorac Cardiovasc Surg Asia. 2013;19(6):441–8.
Beckermann J, Van Camp J, Li S, Wahl SK, Collins A, Herzog CA. On-pump versus off-pump coronary surgery outcomes in patients requiring dialysis: perspectives from a single center and the United States experience. J Thorac Cardiovasc Surg. 2006;131(6):1261–6.
Shroff GR, Li S, Herzog CA. Survival of patients on dialysis having off-pump versus on-pump coronary artery bypass surgery in the United States. J Thorac Cardiovasc Surg. 2010;139(5):1333–8.
Labrousse L, de Vincentiis C, Madonna F, Deville C, Roques X, Baudet E. Early and long term results of coronary artery bypass grafts in patients with dialysis dependent renal failure. Eur J Cardiothorac Surg Off J Eur Assoc Cardiothorac Surg. 1999;15(5):691–6.
Castelli P, Condemi A, Munari M. Immediate and long-term results of coronary revascularization in patients undergoing chronic hemodialysis. Eur J Cardiothorac Surg. 1999;15(1):51–4.
Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol: JASN. 2001;12(5):1079–84.
Salem MM, Mujais S. Coronary revascularization in dialysis patients: the need for vigilance. Int J Artif Organs. 1991;14(1):7–9.
Lockhart ME, Robbin ML, McNamara MM, Allon M. Association of pelvic arterial calcification with arteriovenous thigh graft failure in haemodialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc – Eur Renal Assoc. 2004;19(10):2564–9.
Crawford FA, Selby JH, Bower JD, Lehan PH. Coronary revascularization in patients maintained on chronic hemodialysis. Circulation. 1977;56(4):684–7.
Franga DL, Kratz JM, Crumbley AJ, Zellner JL, Stroud MR, Crawford FA. Early and long-term results of coronary artery bypass grafting in dialysis patients. Ann Thorac Surg. 2000;70(3):813–8. discussion 9.
Charytan DM, Li S, Liu J, Herzog CA. Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation. 2012;126(11 Suppl 1):S164–9.
Owen CH. Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Ann Thorac Surg. 1994;58(6):1729–33.
Baber U, Mehran R, Kirtane AJ, Christodoulidis G, Maehara A, Witzenbichler B, et al. TCT-486 additive and independent impact of chronic kidney disease and diabetes mellitus on high platelet reactivity and adverse events following PCI: results from the ADAPT-DES registry. J Am Coll Cardiol. 2014;64(11_S).
Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375–84.
Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med. 1992;326(1):10–6.
RITA-2 Trial Participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet. 1997;350(9076):461–8.
Hueb WABG, de Oliveira SA, Arie S, de Albuquerque CP, Jatene AD, Pileggi F. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol. 1995;26(7):1600–5.
Yasuda K, Kasuga H, Aoyama T, Takahashi H, Toriyama T, Kawade Y, et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol. 2006;17(8):2322–32.
Mark DB, Nelson CL, Califf RM, Harrell Jr FE, Lee KL, Jones RH, Fortin DF, Stack RS, Glower DD, Smith LR, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89(5):2015–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Warren, J., Baber, U., Mehran, R. (2015). Invasive Management in CAD Patients with Stage 4 Renal Dysfunction or on Dialysis. In: Ambrose, J., RodrÃguez, A. (eds) Controversies in Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-319-20415-4_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-20415-4_19
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20414-7
Online ISBN: 978-3-319-20415-4
eBook Packages: MedicineMedicine (R0)